CT-5126

CT-5126
Clinical data
Other namesCT5126
ATC code
  • None
Identifiers
  • 6,8-dichloro-5-methoxy-3,4-dihydro-2H-1-benzopyran-3-amine
Chemical and physical data
FormulaC10H11Cl2NO2
Molar mass248.10 g·mol−1
3D model (JSmol)
  • C(Cl)1=CC(Cl)=C2OCC(N([H])[H])CC2=C1OC
  • InChI=1S/C10H11Cl2NO2/c1-14-9-6-2-5(13)4-15-10(6)8(12)3-7(9)11/h3,5H,2,4,13H2,1H3
  • Key:GBGLQBXBXUZMLW-UHFFFAOYSA-N

CT-5126 is a cyclized phenethylamine and tetrahydrobenzopyranylamine related to psychedelic phenethylamines like mescaline. In contrast to its non-cyclized analogue CT-5172 (2,6-dimethoxy-3,5-dichlorophenethylamine), the drug was found to have negligible hallucinogen-like effects in cats. CT-5126 was first described in the scientific literature by 1969. Various related analogues, such as CT-5172 and CT-4719, have also been described. CT-5126 and related compounds were developed at the Laboratoire de Chimie Thérapeutique (CT; Therapeutic Chemistry Laboratory) of the Pasteur Institute in Paris, France.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.